Emergence of Colistin-Resistance in Extremely Drug-Resistant Acinetobacter baumannii Containing a Novel pmrCAB Operon During Colistin Therapy of Wound Infections
出版年份 2013 全文链接
标题
Emergence of Colistin-Resistance in Extremely Drug-Resistant Acinetobacter baumannii Containing a Novel pmrCAB Operon During Colistin Therapy of Wound Infections
作者
关键词
-
出版物
JOURNAL OF INFECTIOUS DISEASES
Volume 208, Issue 7, Pages 1142-1151
出版商
Oxford University Press (OUP)
发表日期
2013-06-30
DOI
10.1093/infdis/jit293
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Rapid Killing of Acinetobacter baumannii by Polymyxins Is Mediated by a Hydroxyl Radical Death Pathway
- (2012) Timothy R. Sampson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- High-Dose, Extended-Interval Colistin Administration in Critically Ill Patients: Is This the Right Dosing Strategy? A Preliminary Study
- (2012) L. Dalfino et al. CLINICAL INFECTIOUS DISEASES
- Molecular epidemiology of Acinetobacter baumannii and Acinetobacter nosocomialis in Germany over a 5-year period (2005–2009)
- (2012) X. Schleicher et al. CLINICAL MICROBIOLOGY AND INFECTION
- Use of a surfactant (polysorbate 80) to improve MIC susceptibility testing results for polymyxin B and colistin
- (2012) Helio S. Sader et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Molecular Epidemiology of Acinetobacter baumannii Bloodstream Isolates Obtained in the United States from 1995 to 2004 Using rep-PCR and Multilocus Sequence Typing
- (2012) P. G. Higgins et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Complete Genome Sequence of the Podoviral Bacteriophage YMC/09/02/B1251 ABA BP, Which Causes the Lysis of an OXA-23-Producing Carbapenem-Resistant Acinetobacter baumannii Isolate from a Septic Patient
- (2012) J. Jeon et al. JOURNAL OF VIROLOGY
- Drugs of Last Resort? The Use of Polymyxins and Tigecycline at US Veterans Affairs Medical Centers, 2005–2010
- (2012) Benedikt Huttner et al. PLoS One
- Insertion Sequence ISAba11Is Involved in Colistin Resistance and Loss of Lipopolysaccharide in Acinetobacter baumannii
- (2011) Jennifer H. Moffatt et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- ThepmrCABOperon Mediates Polymyxin Resistance inAcinetobacter baumanniiATCC 17978 and Clinical Isolates through Phosphoethanolamine Modification of Lipid A
- (2011) Luis A. Arroyo et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Phosphoethanolamine Modification of Lipid A in Colistin-Resistant Variants of Acinetobacter baumannii Mediated by the pmrAB Two-Component Regulatory System
- (2011) Alejandro Beceiro et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
- (2011) A.-P. Magiorakos et al. CLINICAL MICROBIOLOGY AND INFECTION
- Sequential outbreaks of multidrug-resistant Acinetobacter baumannii in intensive care units of a tertiary referral hospital in Italy: combined molecular approach for epidemiological investigation
- (2011) F. Ansaldi et al. JOURNAL OF HOSPITAL INFECTION
- Acinetobacter baumannii Resistant to Colistin Alters Its Antibiotic Resistance Profile: A Case Report From Spain
- (2011) Rafael López-Rojas et al. JOURNAL OF INFECTIOUS DISEASES
- Acinetobacter baumannii Resistant to Colistin With Impaired Virulence: A Case Report From France
- (2011) J.-M. Rolain et al. JOURNAL OF INFECTIOUS DISEASES
- Impaired Virulence and In Vivo Fitness of Colistin-Resistant Acinetobacter baumannii
- (2011) Rafael López-Rojas et al. JOURNAL OF INFECTIOUS DISEASES
- Genotypic and phenotypic characterization of the Acinetobacter calcoaceticus–Acinetobacter baumannii complex with the proposal of Acinetobacter pittii sp. nov. (formerly Acinetobacter genomic species 3) and Acinetobacter nosocomialis sp. nov. (formerly Acinetobacter genomic species 13TU)
- (2011) Alexandr Nemec et al. RESEARCH IN MICROBIOLOGY
- In Vitro Activity of the Aminoglycoside Antibiotic Arbekacin against Acinetobacter baumannii-calcoaceticus Isolated from War-Wounded Patients at Walter Reed Army Medical Center
- (2010) M. J. Zapor et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Colistin Resistance in Acinetobacter baumannii Is Mediated by Complete Loss of Lipopolysaccharide Production
- (2010) J. H. Moffatt et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Multiresistant Acinetobacter baumannii infections: epidemiology and management
- (2010) José Garnacho-Montero et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Risk Factors and Outcomes Associated with Acquisition of Colistin-Resistant KPC-Producing Klebsiella pneumoniae: a Matched Case-Control Study
- (2010) O. Zarkotou et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Inducible expression eliminates the fitness cost of vancomycin resistance in enterococci
- (2010) M.-L. Foucault et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Fitness Cost of VanA-Type Vancomycin Resistance in Methicillin-Resistant Staphylococcus aureus
- (2009) M.-L. Foucault et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Resistance to Colistin in Acinetobacter baumannii Associated with Mutations in the PmrAB Two-Component System
- (2009) M. D. Adams et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments
- (2009) S. A. Bustin et al. CLINICAL CHEMISTRY
- Increased Antimicrobial Susceptibility Profiles among Polymyxin‐ResistantAcinetobacter baumanniiClinical Isolates
- (2008) Rodrigo E. Mendes et al. CLINICAL INFECTIOUS DISEASES
- Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
- (2008) Helen W. Boucher et al. CLINICAL INFECTIOUS DISEASES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation